Safety of same-day discharge following vagus nerve stimulator insertion in children: a National Surgical Quality

Jillian DiBiase1, Keith J Kilner1, Eric C Cheon1

  • 11Department of Pediatric Anesthesiology, Ann & Robert H. Lurie Children's Hospital of Chicago.

Insights

Same-day discharge after vagus nerve stimulator (VNS) insertion in children with epilepsy is safe. This study found no increased risk of readmission for pediatric patients discharged on the same day versus those admitted overnight.

Area of Science:

  • Pediatric Surgery
  • Neurology
  • Health Services Research

Background:

  • Vagus nerve stimulator (VNS) insertion is a common treatment for pediatric drug-resistant epilepsy.
  • Optimizing postoperative care for pediatric VNS procedures is crucial due to the increasing number of patients undergoing surgery.

Purpose of the Study:

  • To evaluate readmission and reoperation rates following VNS insertion in children.
  • To determine if same-day discharge impacts postoperative outcomes compared to inpatient admission.

Main Methods:

  • Retrospective analysis of the National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database (2012-2022).
  • Inclusion of 3070 pediatric patients undergoing VNS insertion (CPT code 64568).
  • Primary outcome: unplanned readmission within 7 days; analysis using propensity score matching and multivariable logistic regression.

Main Results:

  • A total of 3070 pediatric patients were analyzed, with 2.1% experiencing unplanned readmission within 7 days.
  • No statistically significant differences in baseline characteristics were observed between same-day discharge and inpatient admission cohorts.
  • Same-day discharge was not associated with a higher rate of unplanned readmissions compared to inpatient admission (OR 1.19, p=0.5).

Conclusions:

  • Same-day discharge for pediatric vagus nerve stimulator insertion is a safe option.
  • Discharge timing (same-day vs. inpatient) does not significantly affect 7-day readmission rates in pediatric epilepsy patients receiving VNS.
Abstract